The effect of myalgic encephalomyelitis/ chronic fatigue syndrome (ME/CFS) severity on cellular bioenergetic function by Tomas C et al.
RESEARCH ARTICLE
The effect of myalgic encephalomyelitis/
chronic fatigue syndrome (ME/CFS) severity
on cellular bioenergetic function
Cara TomasID1*, Joanna L. Elson1,2, Victoria Strassheim3, Julia L. Newton1,3,
Mark Walker1
1 Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United
Kingdom, 2 Centre for Human Metabolomics, North-West University, Potchefstroom, South Africa,
3 Newcastle upon Tyne Hospitals, NHS Foundation Trust, Newcastle upon Tyne, United Kingdom
* cara.tomassmith@nhs.net
Abstract
Myalgic encephalomyelitis/ Chronic fatigue syndrome (ME/CFS) has been associated with
abnormalities in mitochondrial function. In this study we have analysed previous bioenerget-
ics data in peripheral blood mononuclear cells (PBMCs) using new techniques in order to
further elucidate differences between ME/CFS and healthy control cohorts. We stratified our
ME/CFS cohort into two individual cohorts representing moderately and severely affected
patients in order to determine if disease severity is associated with bioenergetic function in
PBMCs. Both ME/CFS cohorts showed reduced mitochondrial function when compared to a
healthy control cohort. This shows that disease severity does not correlate with mitochon-
drial function and even those with a moderate form of the disease show evidence of mito-
chondrial dysfunction. Equations devised by another research group have enabled us to
calculate ATP-linked respiration rates and glycolytic parameters. Parameters of glycolytic
function were calculated by taking into account respiratory acidification. This revealed
severely affected ME/CFS patients to have higher rates of respiratory acidification and
showed the importance of accounting for respiratory acidification when calculating parame-
ters of glycolytic function. Analysis of previously published glycolysis data, after taking into
account respiratory acidification, showed severely affected patients have reduced glycolysis
compared to moderately affected patients and healthy controls. Rates of ATP-linked respi-
ration were also calculated and shown to be lower in both ME/CFS cohorts. This study
shows that severely affected patients have mitochondrial and glycolytic impairments, which
sets them apart from moderately affected patients who only have mitochondrial impairment.
This may explain why these patients present with a more severe phenotype.
Introduction
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a highly heterogeneous dis-
ease with an unknown aetiopathogenesis. There are around 250,000 patients in the UK alone
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with an estimated 25% of patients being severely affected by the disease [1, 2]. Symptoms
include, but are not limited to, severe fatigue lasting more than 6 months, post-exertional mal-
aise, memory and concentration problems and disrupted sleep [3]. ME/CFS has a marked
impact on the quality of life of patients [4, 5]. Our group has previously used extracellular flux
analysis to show that PBMCs from ME/CFS patients have significantly lower mitochondrial
function than healthy controls [6]. Bioenergetic profiling using blood samples is not a new
technique and has been utilised in other studies looking at a range of disease types [7–10]. The
techniques required for investigating mitochondrial function in blood cells are minimally
invasive but provides a wealth of data than allows further understanding of the pathophysiol-
ogy of disease [11]. Blood cells are found systemically therefore it is thought that the bioener-
getic profile of these cells is representative of the body as a whole [12]. However, it is yet to be
determine whether mitochondrial changes in the blood are a cause or consequence of disease.
The ME/CFS cohort in our previous study was comprised of moderately and severely affected
ME/CFS patients but critically did not look to see if the decline in bioenergetic function was
correlated with disease severity. In this study we re-examined the previously published data in
order to investigate the role of mitochondrial and glycolytic function in peripheral blood
mononuclear cells (PBMCs) in disease severity in ME/CFS. Critically there are very few studies
in the field of ME/CFS research include severely affected patients. This is due to the patients in
this group being deemed ‘hard to reach’ as they are housebound or even bedbound by the dis-
ease. The inability of clinicians and researchers to access these patients means that they are
excluded from the majority of ME/CFS studies despite their pressing clinical need. This manu-
script is the first study to look at cellular bioenergetics in severe ME/CFS patients and investi-
gate if they differ from those moderately affected with the disease.
This study also looks at the relative contribution of glycolytic acidification to overall extra-
cellular acidification and how it impacts on the calculation of glycolytic parameters. The gly-
colysis stress test by Agilent Technologies, used to measure extracellular acidification rate
(ECAR) and calculate the glycolytic rates of cells, is based on the presumption that the majority
of protons being moved into the extracellular medium are produced from the conversion of
pyruvate to lactate and the subsequent extrusion of protons from the cell. However, in some
cell types this may not be the case. It has previously been shown that the percentage contribu-
tion of respiratory acidification can vary vastly between cell types with results showing a per-
centage contribution of between 0–100% for different cell types [13]. Respiratory acidification
is caused by the production of CO2 from substrate oxidation. The CO2 is hydrated to carbonic
acid which subsequently dissociates to form bicarbonate and a proton. In the glycolysis stress
test, respiratory acidification can be wrongly attributed to cellular glycolysis as the glycolysis
stress test cannot discriminate between glycolytic acidification and respiratory acidification
when used as directed by the manufacturers. The use of an equation described by Mookerjee
et al allows the percentage contribution of respiratory acidification and glycolytic acidification
to be taken into account when calculating glycolytic parameters from a glycolysis stress test
[13].
Additionally, we performed a calculation of the ATP-linked respiration rate of PBMCs in
the ME/CFS and healthy control cohorts, devised by Mookerjee et al, which enabled us to
determine the individual contribution of glycolysis and oxidative phosphorylation (OXPHOS)
to cellular ATP-linked respiration rates [14]. We were then able to investigate how extracellu-
lar glucose concentrations affected the balance between glycolytic and OXPHOS derived ATP.
This work describes novel investigations into the functioning of energy production path-
ways in ME/CFS cells and is unique in its inclusion of a severely affected cohort in bioenerget-
ics studies for the first time.
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Materials and methods
Participant information
ME/CFS patients were diagnosed by a single physician (JLN) using the Fukuda criteria [3], but
all patients also adhere to the Canadian Consensus Criteria [15]. Ethical approval for the sam-
ple collection from ME/CFS patients was granted from the National Research Ethics Commit-
tee North East–Newcastle & North Tyneside 2. Blood samples from healthy controls were
collected through the Institute of Cellular Medicine (Newcastle University) blood study with
ethical approval from the National Research Ethics Committee North East–County Durham &
Tees Valley. All samples were gathered after informed written consent was obtained.
There were two cohorts of ME/CFS patients with differing levels of disease severity included
in this study. The moderately affected cohort had reduced mobility due to the disease but were
able to attend the local fatigue clinic. Most of the moderately affected patients were able to
walk into the clinic unaided but a small proportion needed the assistance of crutches or a
wheelchair. The severely affected cohort were either housebound or bedbound by the disease
and were unable to attend the clinic even with the use of a wheelchair. This is in line with the
recognised classifications of disease severity in ME/CFS as outlined in the NICE guidelines
and the International Consensus Criteria (ICC) [16, 17]. ME/CFS symptom severity is defined
by the reduction in activity compared to pre-illness. Moderately affected patients are mostly
housebound by the disease while severely affected patients are mostly bedridden [17]. These
seemingly arbitrary categories exist due to the absence of biomarkers in the disease that would
be able to distinguish between the disease severity groups and allow more robust definitions to
be applied.
As severely affected patients were housebound or bedbound by the disease, blood sample
collection happened at the homes of the patients by a nurse. This is in contrast to the moder-
ately affected patients and the healthy controls who had blood collected in a clinical setting.
When setting up the study to collect blood samples from severely affected patients we were
aware of how fatiguing the patients could find such a visit and therefore decided, in order to
minimise the effect on patients, that no other patient information would be collected at the
time of the visit. Therefore we are unable to compare patient demographics between the
groups used here.
PBMC preparation
Blood samples were prepared and PBMCs isolated as described previously in Tomas et al. [6].
Briefly, a density gradient was created using Histopaque1 density gradients and the PBMC
layer collected. PBMCs were then washed twice in fresh PBS and resuspended in RPMI-1640
medium supplemented with 10% FBS and 1% penicillin-streptomycin. Cells were then frozen
at -80˚C in 50% supplemented RPMI-1640 and 50% freezing medium (40% FBS, 10% DMSO).
For cell revival, vials were rapidly defrosted in a water bath at 37˚C and added to 10ml of fresh
supplemented RPMI-1640. Cells were centrifuged at 700 x g for 10 minutes and cells resus-
pended in supplemented RPMI-1640. Trypan blue was used to determine cell viability. All
blood samples were processed within 4 hours of blood collection.
Extracellular flux analysis
Extracellular flux analysis was conducted previously as described in Tomas et al. [6], and the
data re-analysed with different sub-groups.
For mitochondrial respiration the oxygen consumption rate (OCR) of cells was measured
using the Seahorse XFe96 extracellular flux analyser as per the manufacturer’s instructions
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[18]. This included sequential additions of oligomycin, FCCP, and rotenone and antimycin A as
described in Tomas et al. The following parameters were calculated: basal respiration, ATP-linked
respiration, proton leak, maximal respiration, reserve capacity, non-mitochondrial respiration,
and coupling efficiency. Basal respiration is; basal OCR–rotenone and antimycin A OCR. ATP-
linked respiration is; basal OCR–oligomycin OCR. Proton leak is; oligomycin OCR–rotenone
and antimycin A OCR. Maximal respiration is; FCCP OCR–rotenone and antimycin A OCR.
Reserve capacity is; FCCP OCR–basal OCR. Non-mitochondrial respiration is; rotenone and anti-
mycin A OCR. Coupling efficiency is; (ATP-linked respiration/basal respiration)�100.
For glycolytic parameters the extracellular acidification rate (ECAR) of cells was measured
using the Seahorse XFe96 extracellular flux analyser as per the manufacturer’s instructions
[19]. Sequential additions of glucose, oligomycin, and 2-deoxy glucose (2DG) were made as
per manufacturer’s instructions. From this experiments glycolysis, glycolytic capacity, glyco-
lytic reserve, and non-glycolytic acidification were measured. The parameters were calculated
as follows: glycolysis; glucose ECAR –2-DG ECAR. Glycolytic capacity; oligomycin ECAR–
2-DG ECAR. Glycolytic reserve; glycolytic capacity–glycolysis. Non-glycolytic acidification;
2-DG ECAR.
All data was normalised to protein content per well using a bicinchoninic acid (BCA) assay.
Data showing mitochondrial and glycolytic function of PBMCs was examined in order to
take into account disease severity.
Extracellular acidification analysis
Extracellular acidification is attributable to either respiratory or glycolytic activity. These two
parameters add up to the total proton production rate (PPRtot) measured in cells. PPR is
ECAR (the unit of measurement on the seahorse extracellular flux analyser) divided by the
buffering power (BP) of the media used in the experiment (which is 0.1) [20].
PPRtot ¼ ECARtot=BP
In this study we have taken into account glycolytic acidification when calculating cellular
glycolytic parameters. Glycolytic acidification was calculated using the following equation
published my Mookerjee et al [13]:
PPRglyc ¼ ECARtot=BP   ð10
ðpH  pK1Þ=ð1þ 10ðpH  pK1ÞÞÞðmax Hþ=O2ÞðOCRtot   OCRrot=myxÞ
Respiratory acidification is the total proton production rate (PPRtot) measured on the extra-
cellular flux analyser minus the PPRglyc.
PPRresp ¼ PPRtot   PPRglyc
This study also looks at the ATP-linked respiration rates of cells using the samples from the
previously published work. Using equations described in [14] we calculated total ATP-linked
respiration rate, glycolysis ATP-linked respiration rate, OXPHOS ATP-linked respiration rate,
and % contribution of glycolysis to overall ATP-linked respiration rate of PBMCs from ME/
CFS patients and healthy controls. The equations for calculating glycolysis ATP-linked respira-
tion rate (ATPglyc) and OXPHOS ATP-linked respiration rate (ATPOX) are shown below:
ATPglyc ¼ ðPPRglyc � ATP=lactateÞ þ ðOCRmito � 2P=OglycÞ
ATPOX ¼ ðOCRcoupled � 2P=OoxphosÞ þ ðOCRmito � 2P=OTCAÞ
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For more information about these equation please see reference [14]. Total ATP-linked res-
piration rate (ATPtot) is:
ATPtot ¼ ATPglyc þ ATPOX
Statistics
Where two cohorts were compared, student’s or Welch’s t-tests were used to compare groups
depending on whether variances were equal or not. Post hoc Bonferroni corrections were used
when required. Where three cohorts were compared, one-way ANOVAs were used with post-
hoc Tukeys. For the comparison of three cohorts with two different glucose conditions two-
way ANOVAs were applied. Correlations between multiple pairs of bioenergetic parameters
from the mitochondrial stress test were calculated using multi-variate analysis in SPSS. Signifi-
cance levels were set for r-values (r>0.4) and p-values (p<0.01).
Results
Mitochondrial function is impaired in ME/CFS regardless of disease severity
The cellular respiration data shown in Tomas et al was re-analysed to determine if disease
severity affected mitochondrial function [6]. Using the previously published data we separated
the ME/CFS cohort into moderately and severely affected patient cohorts and compared mito-
chondrial parameters from the two groups and also compared the two patient cohorts to the
healthy control cohort previously published in Tomas et al [6]. Results are shown in Fig 1.
For the cellular respiratory parameters, one-way ANOVA showed there to be differences
between groups for the parameters of basal respiration, ATP-linked respiration, proton leak,
maximal respiration, and reserve capacity (p<0.001). When groups were further analysed
using post-hoc Tukeys test and Bonferroni correction, it was shown that both the moderately
and severely affected groups were significantly lower in terms of all five parameters than the
healthy controls (p�0.05). This is in keeping with the previously published data which showed
the ME/CFS cohort as a whole to have significantly lower values for these five parameters [6].
Parameters measured in this assay are inter-dependent with some parameters calculated
from others [18, 21]. To see if the relationships between the parameters differ between the
cohorts used in this study we performed multivariate analysis. Results from this analysis are
shown in Fig 2 and Table 1. As used by other groups in previous publications, we applied mini-
mum threshold values of 0.4 for the r-value and<0.01 for the p-value [22].
The correlation between basal respiration and ATP-linked respiration are very strong for all three
cohorts in the study. This shows the tight coupling between these two parameters is maintained even
in the severely affected patient group. Some of the parameters from the mitochondrial stress test are
calculated using other parameters so relationships between some parameters may be expected, for
example basal respiration is comprised of ATP-linked respiration and proton leak. This is reflected
in the results shown in Fig 2 and Table 1. Graphs for all other correlations can be seen in S1 Appen-
dix. Together the data from the parameter correlations shows that the relationships between some of
the parameters differs between the three cohorts with the only parameters consistently correlated in
all three cohorts being basal respiration and ATP-linked respiration. Further experimental work is
needed to investigate why and how certain relationships become disrupted in ME/CFS PBMCs.
Glycolytic acidification is lower in severely affected ME/CFS patients
The percentage contribution of glycolytic acidification of PBMCs was calculated for the
healthy control cohort, the ME/CFS cohort as a whole, and the moderately and severely
affected patient cohorts. Results are shown in Fig 3.
PLOS ONE The effect of ME/CFS severity on cellular bioenergetic function
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Glycolytic acidification of PBMCs from the ME/CFS cohort as a whole was compared to
that of the healthy controls (Fig 3A). Significant differences in the percentage contribution of
glycolytic acidification to overall extracellular acidification were seen between the two groups
with ME/CFS patients having a lower contribution of glycolytic acidification compared to
healthy controls (p<0.001). However, when the ME/CFS cohort is separated out into the mod-
erately and severely affected groups it becomes clear that the results from the ME/CFS cohort
as a whole are being skewed by the results from the severely affected cohort (Fig 3B). There is a
decrease in the percentage of overall extracellular acidification that can be attributed to glyco-
lytic acidification in the severely affected CFS PBMCs when compared to both the healthy con-
trol and moderately affected ME/CFS cohorts (p�0.002). The decrease in contribution of
glycolytic acidification to overall extracellular acidification in the severely affected group is due
Fig 1. Parameters of cellular respiration (A-G) and glycolytic function (H-K) in PBMCs from moderately and severely affected ME/CFS
patients, and healthy controls. (A) Basal respiration. (B) ATP-linked respiration. (C) Proton leak. (D) Maximal respiration. (E) Reserve
capacity. (F) Non-mitochondrial respiration. (G) Coupling efficiency. Groups were compared using one-way ANOVAs followed by post-hoc
Tukeys and Bonferroni correction. Healthy controls n = 12; moderately affected ME/CFS n = 13; severely affected ME/CFS n = 25. �p�0.05;
���p�0.001.
https://doi.org/10.1371/journal.pone.0231136.g001
PLOS ONE The effect of ME/CFS severity on cellular bioenergetic function
PLOS ONE | https://doi.org/10.1371/journal.pone.0231136 April 10, 2020 6 / 16
to a larger percentage of respiratory acidification. The moderately affected and healthy con-
trols cohorts have comparable levels of glycolytic acidification (p = 0.257) (Fig 3B). It should
be noted that it is a sub-group of severely affected patients that show a decreased glycolytic
acidification with many of the severely affected cohort showing comparable levels to the mod-
erately effected cohort. CO2 acidification, or respiratory acidification, contributes substantially
to the total cellular acidification in severely affected PBMCs and therefore should be taken into
account when measuring ECAR in PBMCs. This shows the importance of separating respira-
tory and glycolytic acidification using the equations devised by Mookerjee et al [13].
Fig 2. Correlations between mitochondrial stress test parameters in PBMCs from healthy controls (n = 12),
moderately affected ME/CFS patients (n = 13), and severely affected ME/CFS patients (n = 25). (A) Correlation
between basal respiration and ATP-linked respiration. (B) Correlation between Basal respiration and proton leak. (C)
Correlation between basal respiration and maximal respiration. (D) Correlation between ATP-linked respiration and
maximal respiration. (E) Correlation between maximal respiration and reserve capacity.
https://doi.org/10.1371/journal.pone.0231136.g002
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Table 1. R-values and correlation p-values for mitochondrial stress test parameters comparisons in PBMCs from healthy controls, moderately affected ME/CFS
patients, and severely affected ME/CFS patients.
Correlation r-values:
Basal respiration ATP-linked respiration Proton leak Maximal respiration Reserve capacity
HC Mod Sev HC Mod Sev HC Mod Sev HC Mod Sev HC Mod Sev
Basal
AL 0.940 0.967 0.926
PL 0.475 0.583 0.099 0.242 0.401 0.002
Maximal 0.911 0.295 0.684 0.831 0.225 0.778 0.491 0.400 0.002
RC 0.780 0.134 0.252 0.697 0.182 0.379 0.452 0.002 0.092 0.966 0.339 0.812
NM 0.114 0.182 0.286 0.168 0.208 0.269 0.002 0.033 0.024 0.167 0.064 0.502 0.195 0.017 0.460
Correlation probability:
Basal respiration ATP-linked respiration Proton leak Maximal respiration Reserve capacity
HC Mod Sev HC Mod Sev HC Mod Sev HC Mod Sev HC Mod Sev
Basal
AL <0.0001 <0.0001 <0.0001
PL 0.013 0.002 0.125 0.104 0.020 0.833
Maximal <0.0001 0.055 <0.0001 <0.0001 0.102 <0.0001 0.011 0.020 0.852
RC <0.0001 0.218 0.011 0.001 0.147 0.001 0.017 0.892 0.140 <0.0001 0.037 <0.0001
NM 0.283 0.146 0.006 0.185 0.117 0.008 0.901 0.554 0.464 0.187 0.406 <0.0001 0.151 0.676 <0.0001
Parameters in bold meet the threshold values of 0.4 for r-values and 0.01 for p-values. AL (ATP-linked); PL (proton leak); RC (reserve capacity); NM (non-
mitochondrial respiration); HC (healthy control); Mod (moderately affected ME/CFS); Sev (severely affected ME/CFS).
https://doi.org/10.1371/journal.pone.0231136.t001
Fig 3. The percentage of overall extracellular acidification that can be attributed to glycolytic acidification in control and ME/CFS
PBMCs. (A) Comparing percentage contribution of glycolytic acidification in PBMCs between a healthy control cohort and an ME/CFS
cohort (containing both moderately and severely affected patients). (B) Comparison of percentage contribution of glycolytic acidification in
PBMCs from a healthy control cohort, moderately affected ME/CFS cohort, and a severely affected ME/CFS cohort. Groups in (A) were
compared using Welch’s t-tests with post-hoc Bonferroni correction. Groups in (B) were compared using a one-way ANOVA with post-hoc
Bonferroni correction. Healthy controls n = 12; whole ME/CFS cohort n = 38; moderately affected ME/CFS n = 13; severely affected ME/CFS
n = 25. �p�0.01; ���p�0.001.
https://doi.org/10.1371/journal.pone.0231136.g003
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Glycolysis is lower in severely affected ME/CFS patients
Our group has previously published data using PBMCs from ME/CFS and healthy control
cohorts to compare glycolytic function of cells using extracellular flux analysis [6]. Glycolysis
was calculated by measuring the extracellular acidification rate after the addition of glucose to
the cells as glycolysis produces protons which are transported to the extracellular medium.
Our previous publication showed ME/CFS and healthy control PBMCs to have comparable
rates of glycolysis. Fig 3 showed there to be higher levels of respiratory acidification in a sub-
group of the severely affected ME/CFS cohort meaning that the original results may not accu-
rately reflect glycolytic activity within the cells as it assumed a minimal contribution of respira-
tory acidification. Re-analysis of the previously published data, in order to take into account
the true contribution of glycolytic acidification to overall ECAR, showed there to be no signifi-
cant differences between in the PBMCs from the ME/CFS cohort as a whole and the healthy
control cohort for any of the glycolytic parameters calculated from a glycolysis stress test
(p�0.263) (S2 Appendix).
There were no significant differences in glycolysis between any of the groups when the ME/
CFS cohort was separated into moderately and severely affected cohorts (Fig 4A). This is con-
sistent with the previous results from our group which found no significant differences in gly-
colysis when all of the ME/CFS patients were analysed as a single cohort [6]. However, when
the moderately and severely affected ME/CFS cohorts were separated and respiratory acidifica-
tion taken into account, the severely affected cohort were shown to have significantly lower
levels of glycolysis than the moderately affected and healthy control cohorts (p�0.036) (Fig
4B). These significant differences between cohorts is caused by the lower levels of glycolytic
acidification seen in the severely affected group (Fig 3B). When the ME/CFS cohort was sepa-
rated into moderately and severely affected cohorts and assessed before and after adjusting for
respiratory acidification, there were no differences seen between any of the groups for the
other three glycolysis parameters—glycolytic capacity, glycolytic reserve, and non-glycolytic
acidification (supplementary data).
Fig 4. Glycolysis in PBMCs from healthy controls and moderate and severely affected ME/CFS patients (published in [6]) before and
after adjusting for the contribution of respiratory acidification to overall extracellular acidification. (A) Glycolysis in PBMCs from
healthy controls (n = 16), moderately affected ME/CFS patients (n = 10), and severely affected ME/CFS patients (n = 9). (B) Glycolysis
adjusted for respiratory acidification. Groups were compared using a one-way ANOVA with post-hoc Bonferroni correction. �p�0.01.
https://doi.org/10.1371/journal.pone.0231136.g004
PLOS ONE The effect of ME/CFS severity on cellular bioenergetic function
PLOS ONE | https://doi.org/10.1371/journal.pone.0231136 April 10, 2020 9 / 16
ATP-linked respiration rate
ATP-linked respiration rates of PBMCs were calculated in cells taken from healthy controls
and moderately affected and severely affected ME/CFS patients. Four aspects of ATP-linked
respiration rates from frozen PBMCs incubated in low (1mM) and high (10mM) extracellular
glucose were compared–total ATP-linked respiration rate(ATPtot); glycolysis ATP-linked res-
piration rate(ATPglyc); OXPHOS ATP-linked respiration rate (ATPox); % contribution of gly-
colysis to overall ATP-linked respiration rate (Fig 5). Comparisons between the three cohorts
showed the severely affected cohort to be significantly lower than the healthy controls in all
four parameters in both low and high glucose (p�0.024). The moderately affected ME/CFS
cohort was shown to be significantly lower than healthy controls in three of the four parame-
ters (ATPglyc; ATPox; ATPtot) in both low and high glucose conditions (p�0.007) but the
groups were not different in terms of % contribution of glycolysis to overall ATP-linked respi-
ration rate (p = 0.271). In low glucose conditions, when the moderately and severely affected
disease cohorts were compared there were no significant differences between the groups
(p�0.126). However, in high glucose differences between the two disease cohorts were
observed with the severely affected patients having significantly lower ATPtot (p<0.001), ATP-
glyc (p = 0.002), and % contribution of glycolysis to overall ATP-linked respiration rate
(p = 0.007). When looking at the effect of glucose concentration on ATP-linked respiration
rate parameters in the three cohorts, significant differences were observed in the healthy con-
trol and moderate ME/CFS cohorts. In the healthy control cohort incubating cells in low glu-
cose caused decreases in ATPtot, ATPglyc, and % contribution of glycolysis to overall ATP-
linked respiration rate when compared with cells incubated in high glucose (p�0.018). ATPox
increased in healthy controls cells incubated in low glucose (p<0.001). For the moderately
affected ME/CFS cohort, both ATPglyc and % contribution of glycolysis to overall ATP-linked
respiration rate were shown to be significantly reduced in low glucose conditions (p�0.049).
The severely affected cohort showed no significant differences between ATP-linked respiration
rates of cells incubated in low and high extracellular glucose (p�0.744).
Discussion
In this study, we analysed data previously published by our group [6] in order to see how dis-
ease severity in ME/CFS relates to mitochondrial and glycolytic function in PBMCs. We have
also calculated ATP-linked respiration rate and glycolysis using new techniques. Previous
studies have shown there to be a correlation between blood cell bioenergetic capacity and both
aerobic and anaerobic activity [10, 23].
There were no differences between the moderately and severely affected ME/CFS groups
for any of the cellular respiratory parameters (Fig 1). This suggests that mitochondrial function
of PBMCs does not correlate with disease severity in ME/CFS and even those moderately
affected by the disease have an impairment in bioenergetic function. The lack of association
between disease severity and mitochondrial function suggests that the previously reported
reduction in mitochondrial function in ME/CFS is not due to deconditioning. If the lower
mitochondrial functioning reported in ME/CFS was due to deconditioning we would expect
to see a significantly lower mitochondrial function in the severely affected cohort who were
housebound or bedbound when compared to the moderately affected cohort [24, 25].
Nor is it due to the presence of deleterious mtDNA variants. A prior paper did not find
mtDNA differences between moderately and severely affected patients despite showing differ-
ences between these two groups and controls [26] Thus this work provides important experi-
mental evidence to support one of the few genetic studies conducted on patients with ME/
CFS.
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Fig 5. ATP-linked respiration rates in PBMCs from healthy controls and moderately and severely affected ME/CFS patients in low
(1mM) and high (10mM) glucose conditions. (A) Total ATP-linked respiration rate. (B) Glycolysis ATP-linked respiration rate. (C)
OXPHOS ATP-linked respiration rate. (D) % contribution of glycolysis to overall ATP-linked respiration rate. (E) Each group plotted as
ATP produced via glycolysis (ATPglyco) against ATP produced via OXPHOS (ATPOX). The dotted line represents equal production of ATP
from glycolysis and OXPHOS. Groups to the right of the line are primarily glycolytic (>50% of ATP derived from glycolysis pathway) while
groups to the left of the line use OXPHOS as the primary pathway for ATP-linked respiration (>50% of ATP produced via OXPHOS).
Groups were compared using two-way ANOVAs with post-hoc Bonferroni correction. Healthy controls low glucose n = 12; Healthy controls
high glucose n = 12; moderately affected ME/CFS low glucose n = 14; moderately affected ME/CFS high glucose n = 13; severely affected ME/
CFS low glucose n = 25; severely affected ME/CFS low glucose n = 25. �p�0.01; ���p�0.001.
https://doi.org/10.1371/journal.pone.0231136.g005
PLOS ONE The effect of ME/CFS severity on cellular bioenergetic function
PLOS ONE | https://doi.org/10.1371/journal.pone.0231136 April 10, 2020 11 / 16
We examined the relative contributions of glycolytic and respiratory acidification to overall
extracellular acidification in PBMCs from ME/CFS patients and healthy controls. Glycolytic
acidification was shown to be significantly lower in the ME/CFS cohort (Fig 3). This suggests
that the contribution of respiratory acidification in ME/CFS PBMCs is significantly higher
than in healthy control cells. However, when the ME/CFS cohort was stratified into moder-
ately and severely affected patients, we showed that the severely affected patient group were
the ones with significantly lower glycolytic acidification, while the moderately affected cohort
had levels of glycolytic acidification comparable to those of healthy controls. This shows this
importance of accurately determining glycolytic acidification before calculating glycolytic
parameters. We have shown that when calculating glycolysis as directed by the manufacturer’s
there are no significant differences between the controls, moderately affected patients, and
severely affected patients. However, when taking into account respiratory acidification we see
that glycolysis is significantly lower in the severely ME/CFS cohort (Fig 4). The data presented
here is in agreement with a metabolic profiling study which showed a reduction in specific
metabolic markers in blood and urine of ME/CFS patients, pointing towards a reduction in
glycolytic activity in ME/CFS [27]. However, caution must be used when interpreting these
results as the lower glycolytic function may be representative of deconditioning in the severely
affected group. In order to confirm or refute this, further studies are needed.
When we examined the ATP-linked respiration rates of PBMCs from ME/CFS patients and
healthy controls, and the effect of glucose concentration on the ATP-linked respiration rates,
we found significant differences between the healthy control and ME/CFS cohorts (Fig 5).
Lower ATP-linked respiration rates were seen in both the moderately and severely affected
ME/CFS cohorts compared to the healthy controls. This reflects the previously published
work, which used calculations from a mitochondrial stress test to approximate ATP-linked res-
piration [6]. These results indicate that there is a defect in the glycolysis and/or OXPHOS path-
ways that leaves patients cells unable to produce adequate levels of ATP. This may contribute
to the symptoms of fatigue and post-exertional malaise which are the hallmarks of ME/CFS.
The severely affected cohort had significantly lower ATPglyc and ATPtot than the moderately
affected cohort in high glucose. The differences in the rates of ATP-linked respiration between
the two patient cohorts may explain why the severely affected patients are rendered bedbound/
housebound by the disease as they have even lower ATP-linked respiration rates than those
moderately affected by the disease. However, whether the differences are a cause or conse-
quence of the disease remains to be determined.
We have shown that differences in glucose concentration affected ATP production rates
from glycolysis and OXPHOS in healthy controls cells. The changes in control PBMCs with
low glucose concentrations followed the pattern we hypothesised–a decrease in glycolysis and
an increase in OXPHOS utilisation. This is because the lower glucose concentration pushes
cells to use OXPHOS to a greater extent due to the higher yield of ATP per glucose molecule
compared with glycolysis. The moderately affected patient cohort shows the same trends for
all four parameters as the controls, although not all differences were significant. The severely
affected cohort showed very little difference between the low and high glucose groups. We
have shown that the control and moderately affected PBMCs are glycolytic in high glucose
conditions but shift towards OXPHOS as the predominant source of energy in low glucose
conditions. Cells from severely affected patients produce their ATP primarily from cellular res-
piration (OXPHOS) in both low and high glucose conditions with very little change in energy
production between the two glucose conditions. It may be that ME/CFS patients, particularly
the severely affected cohort, are already producing ATP at their maximum rate in the high glu-
cose conditions, therefore lowering the glucose concentration has no effect of ATP-linked res-
piration rates. This may indicate abnormalities in factors such as glucose transport, glycolytic/
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OXPHOS enzyme activity, or AMPK function which has previously been shown to be abnor-
mal in ME/CFS skeletal muscle cells [28]. It may also be the case that ME/CFS patient PBMCs
are less able to adapt or are slower at adapting to the low glucose environment.
There are several limitations of this study. PBMCs are a very heterogeneous cell population
that are comprised of a number of different cell types with different bioenergetic demands
[29]. In this study we have used PBMCs rather than stratifying the population out into the sub-
populations of cells that PBMCs are comprised of. This was due to the high number of cells
required to look at each of the PBMC sub-populations in turn. However, if ethical approval
could be obtained in order to collect enough cells to do so, then this stratification would add
strength to the study. Future studies should also look at lipid metabolism (which has been
shown in other studies to be altered in ME/CFS [30–32]) and whether it differs between the
cohorts and how it compares to results seen here in glucose metabolism. The limitation of just
investigating glucose metabolism in these cells means that an overall assessment of cellular bio-
energetics cannot be made. Valuable information would be gained from repeating these types
of experiments and analyses in other cells types in order to see whether these changes are spe-
cific to PBMCs or are more systemic. This work would also benefit from being conducted in
other disease cohorts with fatigue as a core symptom in order to determine whether the
changes in bioenergetics are a marker of the disease ME/CFS or the symptom of fatigue. While
clear differences between cohorts have been identified in this study, even when using robust
and conservative statistical techniques, higher participant numbers, including samples from
multiple international locations, would strengthen the findings.
Conclusions
It is vital that people with different disease severities are included in ME/CFS studies if we are
to move forward with better understanding of ME/CFS pathophysiology. The inclusion of the
two disease severity patient groups has allowed us to identify differences and similarities
between those moderately and severely affected with the disease. The lack of association
between disease severity and mitochondrial function shown here indicates that abnormalities
in mitochondrial function are a feature of the disease irrespective of severity. The lower glyco-
lytic functioning in the severely affected patient group that we have identified is also vital as it
shows that these patients have a glycolytic impairment in addition to the mitochondrial
impairment which may explain why these patients present with a more severe phenotype.
Lower levels of both mitochondrial and glycolytic functioning may be caused by a hypometa-
bolic state in ME/CFS which is linked to disease severity. This work has increased our under-
standing of cellular energy production abnormalities in ME/CFS and how this alters with
disease severity.
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